Literature DB >> 27134702

Hepatitis C virus and neurological damage.

Shilu Mathew1, Muhammed Faheem1, Sara M Ibrahim1, Waqas Iqbal1, Bisma Rauff1, Kaneez Fatima1, Ishtiaq Qadri1.   

Abstract

Chronic hepatitis C virus (HCV) infection exhibits a wide range of extrahepatic complications, affecting various organs in the human body. Numerous HCV patients suffer neurological manifestations, ranging from cognitive impairment to peripheral neuropathy. Overexpression of the host immune response leads to the production of immune complexes, cryoglobulins, as well as autoantibodies, which is a major pathogenic mechanism responsible for nervous system dysfunction. Alternatively circulating inflammatory cytokines and chemokines and HCV replication in neurons is another factor that severely affects the nervous system. Furthermore, HCV infection causes both sensory and motor peripheral neuropathy in the mixed cryoglobulinemia as well as known as an important risk aspect for stroke. These extrahepatic manifestations are the reason behind underlying hepatic encephalopathy and chronic liver disease. The brain is an apt location for HCV replication, where the HCV virus may directly wield neurotoxicity. Other mechanisms that takes place by chronic HCV infection due the pathogenesis of neuropsychiatric disorders includes derangement of metabolic pathways of infected cells, autoimmune disorders, systemic or cerebral inflammation and alterations in neurotransmitter circuits. HCV and its pathogenic role is suggested by enhancement of psychiatric and neurological symptoms in patients attaining a sustained virologic response followed by treatment with interferon; however, further studies are required to fully assess the impact of HCV infection and its specific antiviral targets associated with neuropsychiatric disorders.

Entities:  

Keywords:  Blood brain barrier; Hepatitis C virus; Inflammation; Nervous system; Neuro disorders

Year:  2016        PMID: 27134702      PMCID: PMC4840160          DOI: 10.4254/wjh.v8.i12.545

Source DB:  PubMed          Journal:  World J Hepatol


  120 in total

1.  Severe recurrent myelitis in patients with hepatitis C virus infection.

Authors:  K Marinou Aktipi; S Ravaglia; M Ceroni; R Nemni; M Debiaggi; S Bastianello; E Alfonsi; E Zardini; L Minoli; E Tavazzi; E Marchioni
Journal:  Neurology       Date:  2007-02-06       Impact factor: 9.910

2.  Peripheral and central nervous system involvement in essential mixed cryoglobulinemia: a case report.

Authors:  M Serena; R Biscaro; G Moretto; E Recchia
Journal:  Clin Neuropathol       Date:  1991 Jul-Aug       Impact factor: 1.368

3.  Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis.

Authors:  N Zhu; A Khoshnan; R Schneider; M Matsumoto; G Dennert; C Ware; M M Lai
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Transverse myelitis associated to HCV infection.

Authors:  Diego Michelon De Carli; Jeferson Pannebeker; Fábio Lopes Pedro; Carlos Jesus Pereira Haygert; Everaldo Hertz; Maristela de Oliveira Beck
Journal:  Braz J Infect Dis       Date:  2009-04       Impact factor: 1.949

5.  Cerebral glucose utilisation in hepatitis C virus infection-associated encephalopathy.

Authors:  Meike Heeren; Karin Weissenborn; Dimitrios Arvanitis; Martin Bokemeyer; Annemarie Goldbecker; Argyro Tountopoulou; Thomas Peschel; Julian Grosskreutz; Hartmut Hecker; Ralph Buchert; Georg Berding
Journal:  J Cereb Blood Flow Metab       Date:  2011-06-01       Impact factor: 6.200

6.  Isolated central nervous system vasculitis associated with hepatitis C infection.

Authors:  T M Dawson; G Starkebaum
Journal:  J Rheumatol       Date:  1999-10       Impact factor: 4.666

Review 7.  A review of sleep disturbance in hepatitis C.

Authors:  Sanjeev Sockalingam; Susan E Abbey; Fahad Alosaimi; Marta Novak
Journal:  J Clin Gastroenterol       Date:  2010-01       Impact factor: 3.062

8.  Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry).

Authors:  Manuel Ramos-Casals; Sandra Muñoz; Francisco Medina; Luis-Javier Jara; José Rosas; Jaime Calvo-Alen; Pilar Brito-Zerón; Xavier Forns; Jose-Maria Sánchez-Tapias
Journal:  J Rheumatol       Date:  2009-04-15       Impact factor: 4.666

Review 9.  HCV-related autoimmune and neoplastic disorders: the HCV syndrome.

Authors:  C Ferri; A Antonelli; M T Mascia; M Sebastiani; P Fallahi; D Ferrari; S A Pileri; A L Zignego
Journal:  Dig Liver Dis       Date:  2007-09       Impact factor: 4.088

10.  Hepatitis C virus infection of neuroepithelioma cell lines.

Authors:  Nicola F Fletcher; Jian Ping Yang; Michelle J Farquhar; Ke Hu; Christopher Davis; Qiuchen He; Kimberly Dowd; Stuart C Ray; Sophie E Krieger; Johan Neyts; Thomas F Baumert; Peter Balfe; Jane A McKeating; Flossie Wong-Staal
Journal:  Gastroenterology       Date:  2010-06-09       Impact factor: 22.682

View more
  17 in total

1.  S100B and Inflammatory Cytokine Levels in Blood as Potential Markers of Blood-Brain Barrier Damage and Psychiatric Impairment in Comorbid Hepatitis C Viral Infection and Alcohol Use Disorder.

Authors:  Jennifer M Loftis; Juno Valerio; Jonathan Taylor; Elaine Huang; Rebekah Hudson; Patricia Taylor-Young; Michael Chang; Samuel B Ho; Eric Dieperink; Juan Luis Miranda; Peter Hauser
Journal:  Alcohol Clin Exp Res       Date:  2018-06-28       Impact factor: 3.455

2.  Magnetic resonance imaging in central nervous system vasculitis in a patient affected by crioglobulin-negative hepatitis C virus infection: A likely correlation.

Authors:  Silvia Squarza; Alberto Galli; Maurizio Cariati; Federico Alberici; Valentina Bertolini; Fabio Frediani; Carla Uggetti
Journal:  Neuroradiol J       Date:  2017-07-24

3.  Neuroinvasion and cognitive impairment in comorbid alcohol dependence and chronic viral infection: An initial investigation.

Authors:  Jennifer M Loftis; Jonathan Taylor; Rebekah Hudson; Evan J Firsick
Journal:  J Neuroimmunol       Date:  2019-07-10       Impact factor: 3.478

4.  Peripheral artery disease and physical function in women with and without HIV.

Authors:  Emily R Cedarbaum; Yifei Ma; Adaora A Adimora; Marcas Bamman; Mardge H Cohen; Margaret A Fischl; Deborah Gustafson; Kunihiro Matsushita; Igho Ofotokun; Michael Plankey; Eric C Seaberg; Anjali Sharma; Phyllis C Tien
Journal:  AIDS       Date:  2022-03-01       Impact factor: 4.177

5.  Belief in God's Help During Hepatitis C: A Qualitative Study on Muslim Patients in Pakistan.

Authors:  Malik Muhammad Sohail
Journal:  J Relig Health       Date:  2020-04

Review 6.  Microbial Infections Are a Risk Factor for Neurodegenerative Diseases.

Authors:  Sarah K Lotz; Britanie M Blackhurst; Katie L Reagin; Kristen E Funk
Journal:  Front Cell Neurosci       Date:  2021-07-07       Impact factor: 5.505

Review 7.  The Aging Brain With HIV Infection: Effects of Alcoholism or Hepatitis C Comorbidity.

Authors:  Natalie M Zahr
Journal:  Front Aging Neurosci       Date:  2018-03-22       Impact factor: 5.750

8.  Neurological manifestations in chronic hepatitis C patients receiving care in a reference hospital in sub-Saharan Africa: A cross-sectional study.

Authors:  N Y Mapoure; M N Budzi; S A F B Eloumou; A Malongue; C Okalla; H N Luma
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

9.  Impact of treatment with direct-acting antivirals on anxiety and depression in chronic hepatitis C.

Authors:  Marta Gallach; Mercedes Vergara; Joao Pedro da Costa; Mireia Miquel; Meritxell Casas; Jordi Sanchez-Delgado; Blai Dalmau; Núria Rudi; Isabel Parra; Teresa Monllor; Meritxell Sanchez-Lloansí; Angelina Dosal; Oliver Valero; Xavier Calvet
Journal:  PLoS One       Date:  2018-12-19       Impact factor: 3.240

Review 10.  Hepatic Encephalopathy: From Metabolic to Neurodegenerative.

Authors:  Rafael Ochoa-Sanchez; Farzaneh Tamnanloo; Christopher F Rose
Journal:  Neurochem Res       Date:  2021-06-15       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.